您当前所在的位置:首页 > 产品中心 > 产品详细信息
104-31-4 分子结构
点击图片或这里关闭

2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl 4-(butylamino)benzoate

ChemBase编号:746
分子式:C30H53NO11
平均质量:603.74192
单一同位素质量:603.36186152
SMILES和InChIs

SMILES:
O(CCOCCOCCOCCOCCOC)CCOCCOCCOCCOC(=O)c1ccc(NCCCC)cc1
Canonical SMILES:
COCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)c1ccc(cc1)NCCCC
InChI:
InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3
InChIKey:
MAFMQEKGGFWBAB-UHFFFAOYSA-N

引用这个纪录

CBID:746 http://www.chembase.cn/molecule-746.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl 4-(butylamino)benzoate
IUPAC传统名
@benzonatate
商标名
Benzononantin
Exangit
Tesalon
Tessalin
Tessalon
Tessalon Perles
Tessalon-Ciba
Ventussin
Ventussin-Loz
别名
Benzonatato [INN-Spanish]
Benzonatatum [INN-Latin]
Benzononatine
Benzonatate
CAS号
104-31-4
PubChem SID
46506376
160964209
PubChem CID
7699

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB00868 external link
PubChem 7699 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 11  质子供体
LogD (pH = 5.5) 2.3465576  LogD (pH = 7.4) 2.350569 
Log P 2.3506203  摩尔折射率 161.5422 cm3
极化性 62.730156 Å3 极化表面积 121.4 Å2
可自由旋转的化学键 33  里宾斯基五规则 false 
Log P 2.09  LOG S -5.58 
溶解度 1.59e-03 g/l 

分子性质

分子性质

理化性质 生物活性(PubChem)
溶解度
Soluble in most organic solvents except aliphatic hydrocarbons expand 查看数据来源
疏水性(logP)
1.2 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB00868 external link
Item Information
Drug Groups approved
Description Benzonatate is a non-narcotic oral antitussive (cough suppressant) drug which works by anesthetizing the tissues of the lungs and pleura responsible for the cough reflex. It is chemically related to other ester anesthetics such as procaine. It has an anesthetic (numbing) action similar to that of benzocaine and "numbs" the stretch sensors in the lungs. It is the stretching of these sensors with breathing that causes the cough. It was approved by the FDA in 1958.
Indication For the symptomatic relief of cough. Has also been applied locally in the oral cavity in adults by releasing the drug from the liquid-filled capsules to provide oropharyngeal anesthesia for conscious intubation.
Pharmacology Benzonatate, a non-narcotic antitussive agent chemically related to tetracaine and other ester-type local anesthetics, is used to suppress cough associated with both acute and chronic respiratory conditions. The drug acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura through the dampening of their activity, which reduces the cough reflex.
Toxicity Restlessness, tremors, seizures and unconsciousness.
Affected Organisms
Humans and other mammals
Biotransformation Benzonatate is hydrolyzed to para-aminobenzoic acid (PABA) by plasma esterases
Half Life 3-8 hours
References
Cohen V, Jellinek SP, Stansfield L, Truong H, Baseluos C, Marshall JP: Cardiac arrest with residual blindness after overdose of tessalon(R) (benzonatate) perles. J Emerg Med. 2009 Nov 4. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Cohen V, Jellinek SP, Stansfield L, Truong H, Baseluos C, Marshall JP: Cardiac arrest with residual blindness after overdose of tessalon(R) (benzonatate) perles. J Emerg Med. 2009 Nov 4. Pubmed
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle